EXFLUNA
LIVE

Serial Number

98892128

Owner

GlaxoSmithKline Biologicals SA

Attorney

Elizabeth K. Rucki

Filing Date

Dec 9, 2024

Add to watchlist:

No watchlists yet
View on USPTO

EXFLUNA Trademark

Serial Number: 98892128 • Registration: 8082785

EXFLUNA is a trademark filed by GlaxoSmithKline Biologicals SA on December 9, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

GlaxoSmithKline Biologicals SA (140 trademarks)

Rue de l'Institut 89
B-1330 Rixensart , BE

Entity Type: 99

Trademark Details

Filing Date

December 9, 2024

Registration Date

December 30, 2025

Published for Opposition

November 11, 2025

Goods & Services

Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 30, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 30, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 14, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 16, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 16, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 16, 2025 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 30, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
May 30, 2025 GNSL
SUSPENSION LETTER WRITTEN
May 30, 2025 CNSL
ASSIGNED TO EXAMINER
May 28, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 9, 2024 NWOS
NEW APPLICATION ENTERED
Dec 9, 2024 NWAP